Teva Drops Mylan Bid with US$40.5 B Acquisition of Allergan Generics
By Heather Cartwright & Smita Mishra
Pharma Deals Review: Vol 2015 Issue 8 (Table of Contents)
Published: 19 Aug-2015
DOI: 10.3833/pdr.v2015.i8.2117 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest deal to date, Teva Pharmaceutical Industries has moved to buy Allergan’s generics business for US$40...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS